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Background-—Women have worse outcomes after stroke than men, and this may be partly explained by stroke severity. We
examined factors contributing to sex differences in severity of acute stroke assessed by the National Institutes of Health Stroke
Scale.
Methods and Results-—We pooled individual participant data with National Institutes of Health Stroke Scale assessment (N=6343)
from 8 population-based stroke incidence studies (1996–2014), forming part of INSTRUCT (International Stroke Outcomes Study).
Information on sociodemographics, stroke-related clinical factors, comorbidities, and pre-stroke function were obtained. Within
each study, relative risk regression using log-binominal modeling was used to estimate the female:male relative risk (RR) of more
severe stroke (National Institutes of Health Stroke Scale>7) stratiﬁed by stroke type (ischemic stroke and intracerebral
hemorrhage). Study-speciﬁc unadjusted and adjusted RRs, controlling for confounding variables, were pooled using random-effects
meta-analysis. National Institutes of Health Stroke Scale data were recorded in 5326 (96%) of 5570 cases with ischemic stroke and
773 (90%) of 855 participants with intracerebral hemorrhage. The pooled unadjusted female:male RR for severe ischemic stroke
was 1.35 (95% CI 1.24–1.46). The sex difference in severity was attenuated after adjustment for age, pre-stroke dependency, and
atrial ﬁbrillation but remained statistically signiﬁcant (pooled RRadjusted 1.20, 95% CI 1.10–1.30). There was no sex difference in
severity for intracerebral hemorrhage (RRcrude 1.08, 95% CI 0.97–1.21; RRadjusted 1.08, 95% CI 0.96–1.20).
Conclusions-—Although women presented with more severe ischemic stroke than men, much although not all of the difference
was explained by pre-stroke factors. Sex differences could potentially be ameliorated by strategies to improve pre-stroke health in
the elderly, the majority of whom are women. Further research on the potential biological origin of sex differences in stroke
severity may also be warranted. ( J Am Heart Assoc. 2019;8:e010235. DOI: 10.1161/JAHA.118.010235.)
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W omen are less likely to survive following strokebecause of a higher case fatality rate in the acute
phase, but long-term sex differences in mortality persist up to
5 years after stroke.1 Women also often have poorer
functional outcome, increased participation restriction, and
lower health-related quality of life after stroke than men.1,2
One explanation for these sex differences in outcome is that
women have more severe strokes than men.1–3 While several
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studies have reported on sex differences in the severity of
stroke, most often these studies use severity as a covariate
rather than as a primary outcome.4,5 Another challenge is that
the measurement of severity can differ between studies.6–8
Thus the importance and causes of the association between
sex and stroke severity, remain uncertain.3 Although there are
reports on factors that contribute to severity of stroke (eg,
hypertension,9 cardiovascular diseases,10 dementia,11
embolic stroke mechanism12), the relative importance of
these factors to differences in severity between women and
men has not been investigated thoroughly.
Among the few studies designed to examine the etiology of
sex differences in stroke severity,13,14 there are important
differences in the data sources, methods of analysis, and
adjustment for confounding factors. Renoux et al14 reported
49% (unadjusted odds ratio 1.49, 95% CI 1.23–1.80) increased
odds of having a severe stroke (National Institutes of Health
Stroke Scale [NIHSS] ≥5) for women compared with men,
which was partly explained by age and pre-stroke modiﬁed
Rankin Scale (adjusted odds ratio 1.19, 95% CI 0.94–1.52
following adjustment for these 2 variables). In contrast, Gall
and colleagues reported a 23% (unadjusted relative risk [RR]
1.23, 95% CI 1.05–1.45) greater risk of severe stroke
(NIHSS>7) in women; but the difference was almost completely
explained by women’s older age, presence of dementia, atrial
ﬁbrillation, and pre-stroke Barthel index (adjusted RR 1.05 95%
CI 0.91–1.22).13 Other than age, pre-stroke functional limita-
tions, and comorbidities, there has been limited consideration
on the inﬂuence of other potential confounding factors such as
pre-stroke medication,15 delay in presenting to the hospital,16
and mechanism of ischemic stroke (ie, cardioembolic
strokes)17 on the sex difference in severity.
Examination of a wider range of potential contributors to
any observed sex difference in stroke severity is important to
help address the gaps in our understanding of factors
affecting sex-speciﬁc difference in stroke outcomes. Using
information from an individual participant data (IPD) meta-
analysis we aimed to 1) quantify the sex difference in stroke
severity assessed by initial the National Institutes of Health
Stroke Scale (NIHSS) score among patients with ﬁrst-ever
acute stroke (both ischemic and hemorrhagic); and 2)
investigate the factors (ie, sociodemographics, pre-stroke
health, comorbidities, and clinical factors) that contribute to
any observed difference.
Methods
The data, analytic methods, and study materials will not be
made available to other researchers for purposes of repro-
ducing the results or replicating the procedure. Qualiﬁed
investigators can request access to patient-level data, analytic
methods, and study materials after ethics clearance and
approval by all authors.
The INSTRUCT (International stroke outcomes study)―an
IPD meta-analysis of long-term outcomes after stroke―is a
collaboration of investigators from 13 “gold standard” popu-
lation-based stroke incidence studies (limited to ﬁrst-ever
acute strokes) from Australasia, Europe, South America, and
the Caribbean.1 The INSTRUCT study was registered in the
International prospective register of systematic reviews
(PROSPERO; CRD 42016036723)18 and performed according
to the Preferred Reporting Items for Systematic Review and
Meta-Analyses of individual participant data (PRISMA-IPD)
guidelines.19 Further details about the INSTRUCT study are
provided in Data S1 and Table S1.
Outcome Measurement
Of the 13 studies forming the INSTRUCT, 8 studies had data
on National Institutes of Health Stroke Scale (NIHSS) scores
recorded at the acute stage and so were included in this
analysis. The NIHSS assessment was recorded directly in 7
studies and responses were mapped from Scandinavian
Stroke Scale) data available in 1 other study (Tartu) using
the formula: Scandinavian Stroke Scale =5029NIHSS.20
Predictors of Outcome (Covariates)
We obtained data on a range of covariates in each cohort that
might explain differences in stroke severity between men and
women. These factors included: sociodemographics, pre-
stroke health (functional dependence, comorbidities, health
behaviors, pre-stroke medications), stroke type; acute man-
agement (hospital admission, time delay to hospital presen-
tation), and the year of stroke occurrence (1996–2014).
Details on how these data were collected and the deﬁnitions
Clinical Perspective
What Is New?
• Our article shows that women present with more severe
ischemic stroke than men and the difference is partly
explained by their older age, greater pre-stroke dependency,
and higher prevalence of atrial ﬁbrillation compared with
men.
What are the clinical implications?
• Better preventative health care for women may potentially
reduce their incidence of stroke but also minimize the
severity of strokes if they occur.
• Given the greater severity of these events in women
ensuring that there is equal access to treatments including
thrombolysis and thrombectomy may reduce severity.
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used for each variable in each speciﬁc study are provided in
Data S2 and Table S2.
Available sociodemographic data included race/ethnicity
(2 studies), marital status (4 studies), education (4 studies),
and socioeconomic status (3 studies). Data on pre-stroke
health status included dependence before stroke (4 studies,
modiﬁed Rankin Scale >2; 3 studies, Barthel Index ≤20; 4
studies, institutional residence); comorbidities/medical his-
tory (all studies―atrial ﬁbrillation, hypertension, ischemic
heart disease, transient ischemic attack; 5 studies, peripheral
vascular disease; 4 studies, diabetes mellitus; 3 studies,
dementia); medications before stroke (4 studies, antihyper-
tensives; 4 studies, antiplatelets; 1 study, anticoagulants);
body mass index (5 studies), and health behaviors (7 studies,
smoking status; 6 studies, alcohol use status). Type of stroke
was categorized into 4 groups: ischemic stroke (IS), intrac-
erebral hemorrhage (ICH), subarachnoid hemorrhage, and
undetermined stroke. Ischemic stroke subtypes, available in 4
studies, were categorized by TOAST (Trial of Org 10172 in
Acute Stroke Treatment) classiﬁcation21 including large-artery
atherosclerosis, cardioembolism, small-vessel occlusion, and
other determined etiology.
Statistical Analysis
All analyses were conducted in Stata 12.1. A 2-tailed P≤0.05
was considered statistically signiﬁcant.
Study-speciﬁc analyses of the characteristics of partici-
pants (eg, mean age, percentage of pre-stroke functional
limitation) were compared between men and women and then
pooled using random-effects meta-analysis. We only under-
took analyses for IS and ICH because NIHSS was not routinely
collected for subarachnoid hemorrhage and undetermined
stroke. Stroke severity was dichotomized into severe
(NIHSS>7) or not-severe (NIHSS ≤7).13
Since covariates were not measured uniformly between
studies, we used the 2-stage method of analysis proposed for
IPD meta-analyses.22 The ﬁrst stage involved building study-
speciﬁc unadjusted and adjusted relative risk regression using
log-binomial models to estimate the relative risk of severe
stroke (NIHSS>7 versus ≤7) for women compared with men.
Assuming the confounding role23 of covariates in the
association between sex and severity are similar across
studies, the equivalent covariates were adjusted across
studies. They included age, pre-stroke function, and history
of atrial ﬁbrillation (AF) that were well-established to inﬂuence
sex differences in stroke outcomes1,2 among IS, and age only
for ICH. Adjustment was ﬁrst done for age, and then further
for pre-stroke function, when possible, and AF in multivariable
model. Within each study, we assessed whether these 3
variables and other covariates met the following criteria of
being a confounder (associated with sex, associated with
stroke severity, and the inclusion of the covariate changed the
magnitude of the sex coefﬁcient by ≥10%).24 We tested
whether continuous covariates (ie, age, pre-stroke Rankin, or
pre-stroke Barthel) require a transformation using fractional
polynomials in multivariable modeling,25 to get the best model
ﬁt. Within each study, statistical interactions were assessed
by a test of statistical signiﬁcance of a sex9covariate or
covariate9covariate product term.
For the second stage of the analysis, both unadjusted and
adjusted study-speciﬁc estimates were pooled in separate
random-effects meta-analyses, because of inconsistent study
designs, settings, covariates and outcome measures across
different populations. We also presented estimates from ﬁxed-
effects meta-analyses to compare with the random-effects
approach. Heterogeneity was evaluated using Q statistics and
I2 statistics. Meta-regression was used to identify the sources
of statistically signiﬁcant heterogeneity among study-level
characteristics including the presence of pre-stroke function
data, geographic regions, and proportion of women.
Sensitivity Analyses
We also reported the subgroup analyses of the difference in
severity of IS by TOAST subtype. Given the uncertainty over
the particular cut point to use to deﬁne a severe stroke, we
also undertook a sensitivity analysis by analyzing NIHSS as a
continuous variable to compare with the main results of
dichotomous analyses. Where necessary, transformations of
NIHSS outcome data were performed to remove skewness.
To further test the robustness of our ﬁndings, we used a
single-stage meta-analysis pooling all IPD data sets (8
studies).26 Adjustment for common covariates that are impor-
tant confounders or contributing factors to the association
between sex and stroke severity was performed. Similar to the
analyses using a 2-stage modeling approach, we included age,
the presence of atrial ﬁbrillation, and pre-stroke function when
possible, in multivariable models for IS and age for ICH.
We tried to harmonize the data to conduct a multivariable
analysis of the pooled IPD. Because of inconsistent measures
of (or closely related to) pre-stroke function among 6 studies,
a binary variable of pre-stroke functional limitation was
generated whereby the existing of functional limitation before
stroke was deﬁned as the modiﬁed Rankin Scale >2 (Oxford,
Perth, Tartu), Barthel Index <20 (Melbourne), or being in an
institution (Orebro, Dijon). For those 2 studies without data on
pre-stroke function (Joinville, M~atao), multiple imputation
using chained equations27 (m=50 imputations) was performed
to account for these missing values based on the available
data on NIHSS and covariates in the pooled data set. To
compare with our main ﬁndings using 2-stage approach, we
reported pooled estimates of all 8 studies and a subset of 6
studies with data on pre-stroke function.
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Statistical interactions in multivariable models were also
assessed within the single pooled data set. Year of stroke
occurrence and age that were measured consistently in all
studies were further examined whether they modiﬁed the
relationship between sex and stroke severity.
Results
Sex Difference in Patient Characteristics
Data on initial NIHSS recorded after acute stroke onset were
available among 5326/5570 (95.6%) IS and 773/855 (92.6%)
ICH participants of the 8 studies28–35 (Tables S3 and S4).
Among those with IS, compared with men, women were on
average 4.5 years (95% CI 3.8–5.3) older (statistically signif-
icant difference in 6/8 studies; Table 1) and were less likely
to be living with a spouse (summary estimate 39.4% versus
71.2%, P<0.001; signiﬁcant difference in 3/4 studies).
Women also had higher prevalence of functional limitation
(modiﬁed Rankin Scale >2 or Barthel≤20) before stroke
(summary estimate 22.6% versus 14.0%, P<0.001; signiﬁcant
difference in 2/5 studies) and institutional residence than
men (summary estimate 12.0% versus 4.6%, P<0.001; signif-
icant difference in 3/4 studies). In IS, more women were
prescribed anti-hypertensive agents (3/5 studies) before
stroke than men. Men with IS were more often ever-smokers
(signiﬁcant difference in 7/7 studies) and consumers of
alcohol (signiﬁcant difference in 4/6 studies; Tables S3 and
S4; “IS”). Among ICH participants, women were on average
4.7 years (95% CI 2.6–6.7) older than men (signiﬁcant
difference in only 3/8 studies), and there was few difference
in other baseline characteristics between women and men
(Tables S3 and S4; “ICH”).
Distribution of the NIHSS by sex among those with either
IS or ICH was illustrated in Figure 1 (n=6099; 8 studies) and
Figure S1 (for each study).
Analyses of initial NIHSS scores among 8 studies included
5200/5326 participants with IS (Table 2; 2% of cases were
excluded because of missing data on covariates). In unad-
justed analyses, women with IS were 35% (pooled RR 1.35,
95% CI 1.24–1.46) more likely to suffer more severe strokes
than men; study-speciﬁc crude RRs varied from 1.20 (Perth)
to 1.71 (M~atao; Figure 2, top). We found no statistical
evidence of heterogeneity in unadjusted RR estimates (I2=0%;
Q=4.4, P=0.732) across the studies. In multivariable analysis,
adjustment for age alone reduced the sex difference in
severity by 36% (pooled RRage-adjusted 1.21, 95% CI 1.11–1.31)
with non-statistically signiﬁcant heterogeneity (I2=0%; Q=4.9,
P=0.670). After further accounting for AF and pre-stroke
dependency, the pooled estimate was substantially
attenuated but remained statistically signiﬁcant (pooled
RRfully-adjusted 1.20, 95% CI 1.10–1.30). Although study-
speciﬁc adjusted RRs of the association between sex and
severity of IS varied from 1.09 (Dijon) to 1.70 (M~atao), there
was no statistically signiﬁcant heterogeneity between studies
(I2=0%; Q=4.5, P=0.719; Figure 2, bottom). Factors that
met all criteria for being a confounder were inconsistent
between studies (Table 2). Among IS, these confounding
factors were age (6/8 studies, pre-stroke dependency (5/6
studies), atrial ﬁbrillation (2/8 studies). Transformation of
continuous covariates using fractional polynomials in multi-
variable modeling was not required. None of these factors
modiﬁed the effect of sex on stroke severity (ie, all
sex9covariate or covariate9covariate interactions were
non-signiﬁcant). There was also no evidence that IS subtype
(TOAST; Table S5), or any of the other covariates (eg,
socioeconomic position, education, pre-stroke medications,
alcohol use, and other comorbidities such as diabetes mellitus
and hypertension) contributed to the sex difference in NIHSS
(Table S6).
Analyses of 855/773 participants with ICH (Table 2; 10%
of cases were excluded because of missing data on
confounding factors) found no sex difference in the severity
of stroke (pooled RRunadjusted 1.08, 95% CI 0.97–1.21;
Figure 3, top) without a statistical heterogeneity (I2=0%;
Q=2.1, P=0.957). There was no effect of adjusting for age
with the age-adjusted pooled RR being 1.08, 95% CI 0.96–
1.20 (Figure 3, bottom; I2=0%; Q=1.4, P=0.985) or any other
covariates.
We found no evidence of differences in the pooled
unadjusted or adjusted estimates between random-effects
and ﬁxed-effects meta-analyses, suggesting our results were
robust. Meta-regression did not identify any sources of the
heterogeneity between studies. Neither study-level factors
including geographic region, the availability of pre-stroke
function (Table S7), nor the proportion of women modiﬁed the
sex differences in either unadjusted (IS: Pmeta-regression=0.559; ICH:
Pmeta-regression=0.726) or adjusted analyses (Pmeta-regression=0.403;
ICH: Pmeta-regression=0.723). Removing 2 studies without data
on pre-stroke function (Figures S2 and S3) did not greatly
inﬂuence the pooled estimates compared with the main
results (8 studies; Figures 2 and 3) in either unadjusted (IS:
pooled RRunadjusted 1.30 versus 8 studies 1.35; ICH 1.12
versus 8 studies 1.08) or adjusted analyses (IS: RRadjusted 1.15
versus 8 studies 1.20; ICH: RRunadjusted 1.12 versus 8 studies
1.08).
Sensitivity Analyses
Sensitivity analyses using NIHSS as a continuous variable
showed consistent results to dichotomous analyses
(Table S8).
Our pooled estimates using the single-stage method of
meta-analysis were generally similar (8 studies; IS: RRunadjusted
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1.35, 95% CI 1.23–1.49; RRfully-adjusted 1.19, 95% CI 1.08–
1.32; ICH: RRunadjusted 1.08, 95% CI 0.90–1.29; RRage-adjusted
1.08, 95% CI 0.90–1.29) to our main ﬁndings using the 2-
stage method (IS: Figure 2; ICH: Figure 3). Analyses of IS
among a subset of 6 studies with pre-stroke function data
reassured that our effect estimates did not greatly differ
between these 2 approaches (1-stage RRunadjusted 1.33, 95%
CI 1.18–1.49; RRfully-adjusted 1.15, 95% CI 1.03–1.30 versus 2-
stage RRunadjusted 1.30, 95% CI 1.18–1.44; RRfully-adjusted 1.15,
95% CI 1.04–1.27; Table S7).
In the single pooled data set, we found no statistically
signiﬁcant interactions either between sex and each covariate,
0
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.1
5
.2
0 10 20 30 40 0 10 20 30 40
Men Women
D
en
si
ty
NIHSS
  
Figure 1. Distribution of the National Institutes of Health Stroke Scale scores by sex among those with
stroke (both ischemic and intracerebral hemorrhagic stroke; n=6099). NIHSS indicates National Institutes
of Health Stroke Scale.
Table 2. List of Factors Contributing to the Difference in Stroke Severity Between Women and Men in Multivariable Models by
Stroke Type (more severe stroke was deﬁned as National Institutes of Health Stroke Scale >7)
Study
Ischemic Stroke Intracerebral Hemorrhage
n* Covariates in the Fully Adjusted Model n*
Covariate in the
Fully Adjusted Model
Oxford28 1077 Age (y), pre-stroke mRS, AF 94 Age†
Joinville‡29 1494 Age, AF† 223 Age†
Melbourne30 647 Age, pre-stroke Barthel, AF† 136 Age†
Perth31 123 Age, pre-stroke mRS†, AF† 13 Age†
Orebro32 274 Age†, pre-stroke institutional residence, AF 44 Age†
Dijon33 1238 Age, pre-stroke institutional residence, AF† 197 Age†
M~atao34‡ 67 Age†, AF† 11 Age†
Tartu35 280 Age, pre-stroke mRS, AF† 55 Age†
Pooled 5200 773
AF indicates atrial ﬁbrillation; mRS, modiﬁed Rankin Scale.
*The sample size were the same among the unadjusted model and fully-adjusted model.
†Age, the presence of AF, and pre-stroke function (mRS, Barthel, or institutional residence when possible) were selected to be forced into all the ﬁnal fully adjusted models regardless of
meeting our criteria of being a confounder (associated with NIHSS; associated with sex, and changed the magnitude of the sex coefﬁcient by ≥10%; see Methods, page 8).
‡Data on pre-stroke dependency were unavailable.
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or between covariates inmultivariablemodels. The effect of age
as a confounding factor was similar (IS: pooled RRunadjusted 1.34,
95% CI 1.22–1.49; RRage-adjusted 1.21, 95% CI 1.10–1.34; ICH:
pooled RRunadjusted 1.08, 95% CI 0.90–1.29; RRage-adjusted 1.08,
95% CI 0.90–1.29; Table S9) to the one using the
aforementioned 2-stage approach. There were no evidence
of statistical interactions assessed by a test of statistical
signiﬁcance of a sex9age (continuous) product term (IS:
NOTE: Weights are from random effects analysis
Overall  (I-squared = 0.0%, p = 0.732)
Study
Tartu
Joinville
Mãtao
Melbourne
Perth
Oxford
Dijon
Orebro
Ref
35
29
34
30
31
28
33
32
Date Range, y
02-03
09-14
03-04
96-99
00-01
02-13
06-12
99-00
1.35 (1.24, 1.46)
RR (95% CI)
1.56 (1.16, 2.11)
1.40 (1.19, 1.63)
1.71 (0.92, 3.16)
1.23 (1.00, 1.51)
1.20 (0.76, 1.91)
1.44 (1.17, 1.78)
1.24 (1.05, 1.45)
1.50 (1.01, 2.23)
100.00
Weight
7.34
27.32
1.75
15.68
%
3.11
14.70
25.92
4.20
 Relative risk of more severe ischemic stroke, unadjusted 
1.25 .75 1.25 1.75 2.25
NOTE: Weights are from random effects analysis
Overall  (I-squared = 0.0%, p = 0.719)
Tartu
Orebro
Oxford
Mãtao
Dijon
Study
Perth
Joinville
Melbourne
35
32
28
34
33
Ref
31
29
30
02-03
99-00
02-13
03-04
06-12
Date Range, y
00-01
09-14
96-99
1.20 (1.10, 1.30)
1.27 (0.92, 1.74)
1.37 (0.91, 2.06)
1.18 (0.96, 1.46)
1.70 (0.91, 3.16)
1.09 (0.93, 1.28)
RR (95% CI)
1.10 (0.70, 1.73)
1.30 (1.11, 1.52)
1.13 (0.92, 1.38)
100.00
6.68
4.02
14.92
1.73
25.98
Weight
3.28
27.42
15.98
%
 Relative risk of more severe ischemic stroke, adjusted 
1.25 .75 1.25 1.75 2.25
Figure 2. Difference in stroke severity between women and men with ischemic stroke: unadjusted (top)
and adjusted (bottom) random-effects meta-analyses. More severe stroke was deﬁned as National
Institutes of Health Stroke Scale >7. Both unadjusted and adjusted effect estimates using ﬁxed-effects
meta-analysis were the same compared with those with random-effects approach. RR indicates relative risk.
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Pinteraction=0.793; ICH: Pinteraction=0.324). The magnitude of
the sex differences in severity among those with IS and ICH
was neither modiﬁed by age group (Table S9) and other
covariates. Neither did the year of stroke occurrence modify
the sex differences in stroke severity in both unadjusted (IS:
Pinteraction=0.067; ICH: Pinteraction=0.128) and age-adjusted
analyses (IS: Pinteraction=0.264; ICH: Pinteraction=0.281).
Discussion
We found that women with IS faced a 35% greater risk of
severe stroke than men, and that much of this difference was
explained by pre-stroke factors including: women’s older age,
the presence of functional limitations before stroke and atrial
ﬁbrillation. However, adjustment for these factors did not fully
explain the sex difference and their effects were often
NOTE: Weights are from random effects analysis
Overall  (I-squared = 0.0%, p = 0.957)
Dijon
Study
Tartu
Orebro
Perth
Mãtao
Joinville
Oxford
Melbourne
33
Ref
35
32
31
34
29
28
30
06-12
Date Range, y
02-03
99-00
00-01
03-04
09-14
02-13
96-99
1.08 (0.97, 1.21)
1.09 (0.87, 1.36)
RR (95% CI)
0.96 (0.68, 1.38)
1.05 (0.65, 1.69)
1.43 (0.60, 3.40)
0.89 (0.35, 2.27)
1.05 (0.88, 1.26)
1.04 (0.68, 1.61)
1.24 (0.94, 1.63)
100.00
23.53
Weight
9.32
5.26
1.58
1.35
36.63
%
6.32
16.02
Relative risk of more severe ICH, unadjusted 
1.25 .75 1.25 1.75 2.25
NOTE: Weights are from random effects analysis
Overall  (I-squared = 0.0%, p = 0.985)
Mãtao
Oxford
Tartu
Dijon
Study
Orebro
Joinville
Melbourne
Perth
34
28
35
33
Ref
32
29
30
31
03-04
02-13
02-03
06-12
Date Range, y
99-00
09-14
96-99
00-01
1.08 (0.96, 1.20)
0.95 (0.42, 2.16)
1.08 (0.70, 1.65)
0.98 (0.68, 1.41)
1.08 (0.86, 1.36)
RR (95% CI)
1.16 (0.73, 1.84)
1.04 (0.86, 1.25)
1.19 (0.90, 1.58)
1.35 (0.58, 3.15)
100.00
1.79
6.65
9.08
23.37
Weight
5.77
36.14
15.51
1.70
%
Relative risk of more severe ICH, adjusted for age 
1.25 .75 1.25 1.75 2.25
Figure 3. Difference in stroke severity between women and men with intracerebral hemorrhage (ICH) in
unadjusted (top) and adjusted (bottom) random-effect meta-analyses. More severe stroke was deﬁned as
National Institutes of Health Stroke Scale >7. Both unadjusted and adjusted effect estimates using ﬁxed-
effects meta-analysis were the same compared with those with random-effects approach. ICH indicates
intracerebral hemorrhage; RR, relative risk.
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inconsistent between studies. We also found that there was
no sex difference in severity of ICH.
Because of the more advanced age at stroke onset in
women than men, age was the most important confounding
factor of the association between sex and severity of IS,
accounting for 36% of the sex difference. Older age may be
associated with more severe strokes because of reduced
functional capacity of supporting brain cells, ie, endothelial
cells, and astrocytes after neurological insults.36 The physi-
ological decrease of cerebral blood ﬂow and its regulation that
occurs with increasing age37 potentially inﬂuence neuronal
damage after stroke in the elderly. As a consequence,
impaired brain circulation and subsequent neurological dys-
function might lead to more severe strokes and less recovery
in older adults with stroke. A better understanding of the
pathophysiology of both stroke and cognitive function in the
elderly may have important implications for clinical manage-
ment and preventative strategies. Strategies such as enhanc-
ing geriatric care may help to reduce the poor outcome of
chronic diseases38 including stroke among frail older com-
munity-dwelling adults.39
Pre-stroke function was an important confounding factor of
the sex differences in stroke severity in several (5/6) studies.
The association between more severe stroke in women and
their poorer functional limitation before stroke has been
shown to be correlated with age and several cardiovascular
comorbidities (eg, AF, hypertension, diabetes mellitus) at
baseline.14,40 Poor physical function and interrelated condi-
tions such as frailty, which is more common in women,41 may
reﬂect underlying biologic mechanisms, including chronic
inﬂammation, that play an important role in the pathogenesis
of IS and the severity of brain tissue damage.42 Better
management of comorbid diseases and prevention of frailty in
the elderly43 could help ameliorate the effects of more severe
strokes when they occur in women.13 It is also possible that
poor pre-stroke function and the presence of frailty may
affect the accurate measurement of items in the NIHSS, as
reported by others.44 Combining clinical, imaging, and
biomarker data of the severity of stroke may provide a better
assessment of severity than a single instrument like the
NIHSS.45
Atrial ﬁbrillation (AF) contributed to the sex difference in
severity of IS although surprisingly this was only statistically
signiﬁcant in 2 out of 8 studies (Oxford and Orebro). The
inconsistent ﬁndings may be attributable to the variations in
the data collection and deﬁnition of AF between studies
(Table S2). One reason for more severe strokes in women is
that women with AF more often have cardioembolic strokes
than men.46 In addition, previous studies have found that the
management of AF, speciﬁcally, treatment with anti-
coagulants47 or catheter ablation48 appear to be suboptimal
for women compared with men. It is thus possible that our
observed confounding effect of AF on stroke severity could
reﬂect the widespread under-treatment of AF in older
patients.49 However, we cannot conﬁrm this possibility as
treatments for AF were missing from our data set. This
highlights the need for the better detection and treatment
of AF in both older men and women before stroke
occurrence.50
Age, AF, and pre-stroke function combined only accounted
for 39% of the sex difference in severity of IS (with RR reduced
from 1.35 to 1.20). Other unmeasured or poorly measured
confounding factors could explain the remaining difference.
However, it is also possible that a true biological or
pathophysiological sex difference does exist. Further research
is needed to explore potential biological and clinical mech-
anisms that could lead to a greater stroke severity in women.
Potential dimorphic differences between men and women in
severity of stroke include biologic (eg, hormone-dependent)
and intrinsic (non-hormonal) factors (eg, sex chromosomes).51
Research on biologic mechanisms has established the
neuroprotective effect of hormones in women on IS injury
during premenopause.51 Little is known about how the decline
of sex steroid hormones in women after menopause and
ovariectomy inﬂuences the sex disparities in post-stroke
neurologic deﬁcits. Further examination of the sex differences
in neurologic function, speciﬁcally injury response and
recovery after stroke with regard to different age groups,
are needed. Infarct size and location of stroke appear to
inﬂuence the level of neurologic deﬁcits and eventual stroke
outcomes eg, left-hemispheric ischemic strokes are more
frequent and often have higher admission NIHSS scores as
well as poorer survival than right-hemispheric counterparts.52
However, few authors have attempted to unravel the relative
role of these factors in the severity differences across the
different patient groups including men and women, or young
and older people. Recent advanced brain imaging undertaken
to investigate neurological deﬁcits among people with differ-
ent stroke types may offer better opportunities to understand
the sex and age differences in brain injury.53 Also, female
members are often excluded in the neuroscience experiments
because of the hormonal ﬂuctuations associated with the
reproductive cycle.54 A recent meta-analysis of neuroscience
studies has shown that data from female rats are no more
variable than data from males.55 This suggests a need to
include females in animal models to understand the sex
difference in severity of stroke.56
The sex differences in stroke severity existed for IS but not
ICH. In our analyses, age, pre-stroke function, and AF were
contributing factors to more severe strokes in women. By
contrast, there were no evidence of the confounding effects in
the ICH group (the unadjusted and adjusted estimates were
the same). The reasons for this difference is unclear. It may be
related to the differences in the underlying mechanisms
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between these 2 types of stroke.57 Further research is
warranted to examine the uncertainty over the sex differences
in stroke severity among women and men with ICH. Our study
has a number of strengths. To our knowledge, we have
provided the ﬁrst pooled estimates of sex differences in
stroke severity, separately for IS and ICH. We compiled the
IPD from 8 population-based studies from various regions of
the world. The use of 2-stage method for meta-analysis of IPD
allowed us to overcome some of the limitations that result
from not all potential confounding factors being measured
across all studies.22 The data came from high-quality popu-
lation-based studies free of the limitations of hospital-based
or convenience samples and had a large sample, making this
study adequately powered to test our hypotheses.
However, limitations need to be acknowledged. The
population-based studies in our research networks are mostly
from high-income countries (7/8 studies), potentially leading
to less generalizable results. We were unable to include 5
studies because NIHSS data were not available (Table S1)
thereby reducing the statistical power. The methods and
sources of data collection differed across cohorts, and this
may have contributed to the differing confounding variables
identiﬁed between studies. In particular, our inability to detect
whether IS subtypes confounded the association between sex
and severity is likely attributable to the scarce data on IS
subtypes (TOAST classiﬁcation) which were only collected in 4
studies. Further research is needed to explore the role of the
mechanism of IS on the sex difference in severity of stroke.
There was a lack of data on subdomain scores of NIHSS,
another potential contributor to the sex difference in severity
of stroke. Although the rate of missing data on NIHSS and
covariates (<10%) was low enough that imputation of missing
data was not required, we could not eliminate the possibility
of some selection bias. Finally, the number of studies forming
our pooled estimates was less than required (≥10) for the
exploration of heterogeneity between studies using meta-
regression.58
Conclusion
In clinical practice, women are more likely to present with
severe IS than men but the difference is partly explained by
their advanced age, greater pre-stroke functional limitation
and presence of AF. Given these ﬁndings, strategies to
improve pre-stroke health and access to evidence-based care
for the elderly could help reduce differences in stroke severity
between men and women. In addition, understanding the
origin of more severe strokes in women compared with men
should be a priority area for further research, more studies
that attempt to identify other potential explanatory factors
such as IS stroke mechanism, treatment of AF, and other
comorbidities are needed.
Author Contributions
All authors satisfying the 4 criteria for authorship recommended
by International Committee of Medical Journal Editors, as
speciﬁed: Substantial contributions to the conception or design
of the work (Dr Phan, Dr Gall, Dr Reeves, Dr Blizzard, Dr Thrift,
Dr Cadilhac, Dr Heeley, Dr Sturm, and Mr Otahal) and the
acquisition, analysis, or interpretation of data for the work (all
authors); drafting the work or revising it critically for important
intellectual content (all authors); ﬁnal approval of the version to
be published (all authors); agreement to be accountable for all
aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately
investigated and resolved (all authors).
Sources of Funding
Chief investigators for each of the studies provided their data at
no cost. Phan is supported by a Merle Weaver Postgraduate
Scholarship (University of Tasmania). Gall is supported by a
National Heart Foundation of Australia Future Leader Fellowship
(FLF 100446). Reeves was supported by a Menzies Institute
Visiting Scholars Program (Tasmania, Australia). The following
authors received research fellowship funding from the National
Health and Medical Research Council (NHMRC): Thrift
(1042600), Cadilhac (co-funded Heart Foundation: 1063761)
and CA (1081356). The NHMRC also provided support for the
study conducted in Melbourne (154600, 307900), as did
VicHealth and the Stroke Foundation (Australia). The Brazilian
National Council for Scientiﬁc and Technological Development
(CNPq) funded the research conducted in Joinville (grant number
402396/2013-8). The Dijon Stroke Registry is supported by
InVS and INSERM. The Oxford Vascular Study is funded by the
Wellcome Trust, StrokeAssociation, and theNational Institute of
Health Research Biomedical Research Centre, Oxford.
Disclosures
None.
References
1. Phan HT, Blizzard CL, Reeves MJ, Thrift AG, Cadilhac D, Sturm J, Heeley E,
Otahal P, Konstantinos V, Anderson C, Parmar P, Krishnamurthi R, Barker-Collo
S, Feigin V, Bejot Y, Cabral NL, Carolei A, Sacco S, Chausson N, Olindo S,
Rothwell P, Silva C, Correia M, Magalhaes R, Appelros P, Korv J, Vibo R, Minelli
C, Gall S. Sex differences in long-term mortality after stroke in the INSTRUCT
(INternational STRoke oUtComes sTudy): a meta-analysis of individual
participant data. Circ Cardiovasc Qual Outcomes. 2017;10:e003436.
2. Phan HT, Blizzard CL, Reeves MJ, Thrift AG, Cadilhac DA, Sturm J, Heeley E,
Otahal P, Vemmos K, Anderson C, Parmar P, Krishnamurthi R, Barker-Collo S,
Feigin V, Bejot Y, Cabral NL, Carolei A, Sacco S, Chausson N, Olindo S,
Rothwell P, Silva C, Correia M, Magalh~aes R, Appelros P, K~orv J, Vibo R, Minelli
C, Gall SL. Factors contributing to sex differences in functional outcomes and
participation after stroke. Neurology. 2018;90:e1945–e1953.
3. Reeves MJ, Bushnell CD, Howard G, Gargano JW, Duncan PW, Lynch G,
Khatiwoda A, Lisabeth L. Sex differences in stroke: epidemiology, clinical
presentation, medical care, and outcomes. Lancet Neurol. 2008;7:915–926.
DOI: 10.1161/JAHA.118.010235 Journal of the American Heart Association 10
Sex Differences in Severity of Stroke Phan et al
S
Y
S
T
E
M
A
T
IC
R
E
V
IE
W
A
N
D
M
E
T
A
-A
N
A
L
Y
S
IS
D
ow
nloaded from
 http://ahajournals.org by on December 28, 2018
4. Bushnell CD, Reeves MJ, Zhao X, Pan W, Prvu-Bettger J, Zimmer L, Olson D,
Peterson E. Sex differences in quality of life after ischemic stroke. Neurology.
2014;82:922–931.
5. Wang Z, Li J, Wang C, Yao X, Zhao X, Wang Y, Li H, Liu G, Wang A, Wang Y.
Gender differences in 1-year clinical characteristics and outcomes after
stroke: results from the China National Stroke Registry. PLoS One. 2013;8:
e56459.
6. Dehlendorff C, Andersen KK, Olsen TS. Sex disparities in stroke: women have
more severe strokes but better survival than men. J Am Heart Assoc. 2015;4:
e001967. DOI: 10.1161/JAHA.115.001967.
7. Zhou J, Zhang Y, Arima H, Zhao Y, Zhao H, Zheng D, Tian Y, Liu Y, Huang Q,
Yang J; for the Nanjing First Hospital Stroke Registry I. Sex differences in
clinical characteristics and outcomes after intracerebral haemorrhage: results
from a 12-month prospective stroke registry in Nanjing, China. BMC Neurol.
2014;14:172.
8. Salihovic D, Smajlovic D, Sinanovic O, Kojic B. Sex differences in patients with
acute ischemic stroke in Tuzla region, Bosnia and Herzegovina. Bosn J Basic
Med Sci. 2010;10:116–120.
9. Faraji F, Ghasami K, Talaie-Zanjani A, Mohammadbeigi A. Prognostic factors in
acute stroke, regarding to stroke severity by Canadian Neurological Stroke
Scale: a hospital-based study. Asian J Neurosurg. 2013;8:78–82.
10. Kakar P, Boos CJ, Lip GYH. Management of atrial ﬁbrillation. Vasc Health Risk
Manag. 2007;3:109–116.
11. Appelros P, Nydevik I, Seiger A, Terent A. Predictors of severe stroke:
inﬂuence of preexisting dementia and cardiac disorders. Stroke. 2002;33:
2357–2362.
12. Arboix A, Alio J. Cardioembolic stroke: clinical features, speciﬁc cardiac
disorders and prognosis. Curr Cardiol Rev. 2010;6:150–161.
13. Gall SL, Donnan G, Dewey HM, Macdonell R, Sturm J, Gilligan A, Srikanth V,
Thrift AG. Sex differences in presentation, severity, and management of stroke
in a population-based study. Neurology. 2010;74:975–981.
14. Renoux C, Coulombe J, Li L, Ganesh A, Silver L, Rothwell PM. Confounding by
pre-morbid functional status in studies of apparent sex differences in severity
and outcome of stroke. Stroke. 2017;48:2731–2738.
15. Park JM, Kang K, Cho YJ, Hong KS, Lee KB, Park TH, Lee SJ, Ko Y, Han MK, Lee
J, Cha JK, Kim DH, Kim DE, Kim JT, Choi JC, Yu KH, Lee BC, Lee JS, Lee J,
Gorelick PB, Bae HJ. Comparative effectiveness of prestroke aspirin on stroke
severity and outcome. Ann Neurol. 2016;79:560–568.
16. Oh MS, Yu KH, Roh JK, Lee BC. Gender differences in the mortality and
outcome of stroke patients in Korea. Cerebrovasc Dis. 2009;28:427–434.
17. Bill O, Zufferey P, Faouzi M, Michel P. Severe stroke: patient proﬁle and
predictors of favorable outcome. J Thromb Haemost. 2013;11:92–99.
18. Phan H, Blizzard L, Thrift A, Cadilhac D, Reeves M, Sturm J, Gall S. Sex
difference in long-term outcomes of stroke in the INternational STroke
oUtComes sTudy (INSTRUCT): a meta-analysis of individual patient data.
PROSPERO 2016:CRD42016036723. York, United Kingdom: Centre for
Reviews and Dissemination, University of York; 2016. Available at: http://
www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016036723.
Accessed September 12, 2016.
19. Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, Tierney JF.
Preferred reporting items for systematic review and meta-analyses of individual
participant data: the PRISMA-IPD statement. JAMA. 2015;313:1657–1665.
20. Ali K, Cheek E, Sills S, Crome P, Roffe C. Development of a conversion factor
to facilitate comparison of National Institute of Health Stroke Scale scores
with Scandinavian Stroke Scale scores. Cerebrovasc Dis. 2007;24:509–515.
21. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE
III. Classiﬁcation of subtype of acute ischemic stroke. Deﬁnitions for use in a
multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
Stroke. 1993;24:35–41.
22. Stukel TA, Demidenko E, Dykes J, Karagas MR. Two-stage methods for the
analysis of pooled data. Stat Med. 2001;20:2115–2130.
23. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J
Public Health. 1989;79:340–349.
24. Gall SL, Tran PL, Martin K, Blizzard L, Srikanth V. Sex differences in long-term
outcomes after stroke: functional outcomes, handicap, and quality of life.
Stroke. 2012;43:1982–1987.
25. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model
continuous risk variables in epidemiology. Int J Epidemiol. 1999;28:964–974.
26. Stewart GB, Altman DG, Askie LM, Duley L, Simmonds MC, Stewart LA.
Statistical analysis of individual participant data meta-analyses: a comparison
of methods and recommendations for practice. PLoS One. 2012;7:e46042.
27. White IR, Royston P, Wood AM. Multiple imputation using chained equations:
Issues and guidance for practice. Stat Med. 2011;30:377–399.
28. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, Gutnikov SA,
Edwards P, Mant D, Sackley CM, Farmer A, Sandercock PA, Dennis MS,
Warlow CP, Bamford JM, Anslow P. Change in stroke incidence, mortality,
case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004
(Oxford Vascular Study). Lancet. 2004;363:1925–1933.
29. Cabral NL, Goncalves AR, Longo AL, Moro CH, Costa G, Amaral CH, Fonseca
LA, Eluf-Neto J. Incidence of stroke subtypes, prognosis and prevalence of risk
factors in Joinville, Brazil: a 2 year community based study. J Neurol Neurosurg
Psychiatry. 2009;80:755–761.
30. Sturm JW, Donnan GA, Dewey HM, Macdonell RA, Gilligan AK, Thrift AG.
Determinants of handicap after stroke: the North East Melbourne Stroke
Incidence Study (NEMESIS). Stroke. 2004;35:715–720.
31. Anderson CS, Jamrozik KD, Broadhurst RJ, Stewart-Wynne EG. Predicting
survival for 1 year among different subtypes of stroke. Results from the Perth
Community Stroke Study. Stroke. 1994;25:1935–1944.
32. Appelros P, Nydevik I, Seiger A, Terent A. High incidence rates of stroke in
Orebro, Sweden: further support for regional incidence differences within
Scandinavia. Cerebrovasc Dis. 2002;14:161–168.
33. Bejot Y, Catteau A, Caillier M, Rouaud O, Durier J, Marie C, Di Carlo A, Osseby
GV, Moreau T, Giroud M. Trends in incidence, risk factors, and survival in
symptomatic lacunar stroke in Dijon, France, from 1989 to 2006: a
population-based study. Stroke. 2008;39:1945–1951.
34. Minelli C, Fen LF, Minelli DP. Stroke incidence, prognosis, 30-day, and 1-year
case fatality rates in Matao, Brazil: a population-based prospective study.
Stroke. 2007;38:2906–2911.
35. Korv J, Roose M, Kaasik A-E. Stroke registry of Tartu, Estonia, from 1991
through 1993. Cerebrovasc Dis. 1997;7:154–162.
36. Sohrabji F, Bake S, Lewis DK. Age-related changes in brain support cells:
implications for stroke severity. Neurochem Int. 2013;63:291–301.
37. Strandgaard S. Cerebral blood ﬂow in the elderly: impact of hypertension and
antihypertensive treatment. Cardiovasc Drugs Ther. 1991;4(Suppl 6):1217–
1221.
38. Gur AY, Tanne D, Bornstein NM, Milo R, Auriel E, Shopin L, Koton S. Stroke in
the very elderly: characteristics and outcome in patients aged >/=85 years
with a ﬁrst-ever ischemic stroke. Neuroepidemiology. 2012;39:57–62.
39. Golden AG, Tewary S, Dang S, Roos BA. Care management’s challenges and
opportunities to reduce the rapid rehospitalization of frail community-dwelling
older adults. Gerontologist. 2010;50:451–458.
40. Di Legge S, Koch G, Diomedi M, Stanzione P, Sallustio F. Stroke prevention:
managing modiﬁable risk factors. Stroke Res Treat. 2012;2012:391538.
41. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman
T, Tracy R, Kop WJ, Burke G, McBurnie MA. Frailty in older adults: evidence for
a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–M156.
42. Jin R, Yang G, Li G. Inﬂammatory mechanisms in ischemic stroke: role of
inﬂammatory cells. J Leukoc Biol. 2010;87:779–789.
43. Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, Cesari M,
Chumlea WC, Doehner W, Evans J, Fried LP, Guralnik JM, Katz PR, Malmstrom
TK, McCarter RJ, Gutierrez Robledo LM, Rockwood K, von Haehling S,
Vandewoude MF, Walston J. Frailty consensus: a call to action. J Am Med Dir
Assoc. 2013;14:392–397.
44. Abdul-Rahim AH, Fulton RL, Sucharew H, Kleindorfer D, Khatri P, Broderick JP,
Lees KR. National Institutes of Health Stroke Scale item proﬁles as predictor
of patient outcome. Stroke. 2015;46:395.
45. Barbieri A, Giuliani E, Carone C, Pederzoli F, Mascheroni G, Greco G, Stucchi C,
Genedani S. Clinical severity of ischemic stroke and neural damage
biomarkers in the acute setting: the STROke MArkers (STROMA) study.
Minerva Anestesiol. 2013;79:750–757.
46. Wagstaff AJ, Overvad TF, Lip GY, Lane DA. Is female sex a risk factor for stroke
and thromboembolism in patients with atrial ﬁbrillation? A systematic review
and meta-analysis QJM. 2014;107:955–967.
47. Gage BF, Boechler M, Doggette AL, Fortune G, Flaker GC, Rich MW, Radford
MJ. Adverse outcomes and predictors of underuse of antithrombotic therapy in
medicare beneﬁciaries with chronic atrial ﬁbrillation. Stroke. 2000;31:822–
827.
48. Patel D, Mohanty P, Di Biase L, Sanchez JE, Shaheen MH, Burkhardt JD,
Bassouni M, Cummings J, Wang Y, Lewis WR, Diaz A, Horton RP, Beheiry S,
Hongo R, Gallinghouse GJ, Zagrodzky JD, Bailey SM, Al-Ahmad A, Wang P,
Schweikert RA, Natale A. Outcomes and complications of catheter ablation for
atrial ﬁbrillation in females. Heart Rhythm. 2010;7:167–172.
49. Yiin GS, Howard DP, Paul NL, Li L, Luengo-Fernandez R, Bull LM, Welch SJ,
Gutnikov SA, Mehta Z, Rothwell PM. Age-speciﬁc incidence, outcome, cost,
and projected future burden of atrial ﬁbrillation-related embolic
vascular events: a population-based study. Circulation. 2014;130:1236–
1244.
DOI: 10.1161/JAHA.118.010235 Journal of the American Heart Association 11
Sex Differences in Severity of Stroke Phan et al
S
Y
S
T
E
M
A
T
IC
R
E
V
IE
W
A
N
D
M
E
T
A
-A
N
A
L
Y
S
IS
D
ow
nloaded from
 http://ahajournals.org by on December 28, 2018
50. Desai Y, El-Chami MF, Leon AR, Merchant FM. Management of atrial ﬁbrillation
in elderly adults. J Am Geriatr Soc. 2017;65:185–193.
51. Gibson CL. Cerebral ischemic stroke: is gender important? J Cereb Blood Flow
Metab. 2013;33:1355–1361.
52. Hedna VS, Bodhit AN, Ansari S, Falchook AD, Stead L, Heilman KM, Waters
MF. Hemispheric differences in ischemic stroke: is left-hemisphere stroke
more common? J Clin Neurol. 2013;9:97–102.
53. Etherton MR, Wu O, Cougo P, Giese AK, Cloonan L, Fitzpatrick KM, Kanakis AS,
Boulouis G, Karadeli HH, Lauer A, Rosand J, Furie KL, Rost NS. Structural
integrity of normal appearing white matter and sex-speciﬁc outcomes after
acute ischemic stroke. Stroke. 2017;48:3387–3389.
54. Beery AK, Zucker I. Sex bias in neuroscience and biomedical research.
Neurosci Biobehav Rev. 2011;35:565–572.
55. Becker JB, Prendergast BJ, Liang JW. Female rats are not more variable than
male rats: a meta-analysis of neuroscience studies. Biol Sex Differ. 2016;7:34.
56. McCullough LD, de Vries GJ, Miller VM, Becker JB, Sandberg K, McCarthy MM.
NIH initiative to balance sex of animals in preclinical studies: generative questions
to guide policy, implementation, and metrics. Biol Sex Differ. 2014;5:15.
57. An SJ, Kim TJ, Yoon BW. Epidemiology, risk factors, and clinical features of
intracerebral hemorrhage: an update. J Stroke. 2017;19:3–10.
58. Green S, Higgins J. Cochrane handbook for systematic reviews of interventions
version 5.1.0. The Cochrane Collaboration; 2011.
DOI: 10.1161/JAHA.118.010235 Journal of the American Heart Association 12
Sex Differences in Severity of Stroke Phan et al
S
Y
S
T
E
M
A
T
IC
R
E
V
IE
W
A
N
D
M
E
T
A
-A
N
A
L
Y
S
IS
D
ow
nloaded from
 http://ahajournals.org by on December 28, 2018
SUPPLEMENTAL MATERIAL 
D
ow
nloaded from
 http://ahajournals.org by on December 28, 2018
 
 
Data S1. 
 
Supplemental Methods 
 
Search strategy, search term, data collection and data management 
Our study was a collaboration between investigators for 13 population-based incidence studies identified 
through a previous systematic review,1 and our research networks. To understand how representative these 
studies were of all possible studies we undertook a systematic literature search of the literature published after 
the aforementioned systematic review, as detailed below. 
Search strategy  
We identified potential studies using previous systematic reviews of these ‘ideal’ stroke incidence studies1,2 
supplemented with an updated search for new studies published since May 2008, the end date for the systematic 
review by Feigin et al.1 We systematically searched population-based studies from academic databases 
(PubMed, Scopus, Embase and ScienceDirect) aiming to identify all ‘ideal’ incidence studies conducted 
between May 2008 and May 2014 with terms “stroke”, “isch(a)emic stroke”, “intracerebral”, 
“intraparenchymal”, “subarachnoid”, “h(a)emorrhage”, “population-based”, “community-based”, “community”, 
“epidemiology”, “epidemiological”, “incidence”, “attack rates”, “survey”, “surveillance”, “mortality”, 
“morbidity”, “fatality”, “case fatality”, or “trends”.  
Our inclusion criteria comprised any stroke incidence study which met criteria of ‘gold standard’,2,3 restricted to 
human studies only and published in the English language. These studies have standardised methods to ensure 
high quality data, including standard definitions for first-ever-in-a-lifetime stroke; a prospective design, 
population-based case ascertainment from multiple overlapping sources from inside and outside hospital 
systems; subtyping of a large proportion of events using imaging; a large and preferably stable population base; 
and surveillance over at least one year to control for seasonal variation in stroke occurrence. Our exclusion 
criteria was any population-based study which was not an adequate design (e.g. age limitation, ischemic stroke 
only).  
We then established whether investigators of all eligible studies identified by reviews and updated search had 
published on outcomes at 1 or more years after stroke. We then invited those who had published these outcomes 
to participate. Where repeat incidence studies with assessments were conducted over time, we requested access 
to the follow-up data from the most recent incidence study.  
Two reviewers (HP, SG) performed an online database search separately to identify eligible studies based on 
title or abstract and, where necessary, review the full-text article. References list of studies were also searched 
for additional eligible articles, while unpublished data were identified from contact with authors. Each reviewer 
also performed an assessment to determine which studies met our inclusion criteria and all these activities were 
undertaken with each reviewer blinded to the results. Disagreements were resolved via consensus.  
Our search strategy identified 28 new ‘ideal’ studies in addition to 56 population-based studies identified by the 
previous systematic review. Of these, 22 ‘ideal’ population-based stroke incidence studies had published on 
follow-up of participants at 1 year or more after stroke. We approached investigators of 17 eligible studies with 
long term follow-up to participate, with 13 agreeing. The main reasons for exclusion of 9 studies occurred due 
to refusal to participate (4 studies) and late identification of the study (5 studies). 
Search term 
Pubmed (n=1851) 
Search ((“stroke”[Title] OR “isch(a)emic stroke”[Title] OR “intracerebral”[Title] OR “intraparenchymal”[Title] 
OR “subarachnoid”[Title] OR “h(a)emorrhage”[Title])) AND (“population-based”[Title] OR “community-
based”[Title] OR “community”[Title] OR “epidemiology”[Title] OR “epidemiological”[Title] OR 
“incidence”[Title] OR “attack rates”[Title] OR “survey”[Title] OR “surveillance”[Title] OR “mortality”[Title] 
OR “morbidity”[Title] OR “fatality”[Title] OR “case fatality”[Title] OR “trends”[Title]) Filters: Publication 
date from 2008/05/01 to 2014/05/01; English 
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Embase (n=721) 
(1) 'population-based' OR 'community-based' OR 'community' OR 'epidemiology' OR 'epidemiological' 
OR 'incidence' OR 'attack rates' OR 'survey' OR 'surveillance' OR 'ideal study' OR 'mortality' OR 'morbidity' OR 
'fatality' OR 'case fatality' OR 'trends' OR 'population-based' OR 'community-based' OR 'community' OR 
'epidemiology' OR 'epidemiological' OR 'incidence' OR 'attack rates' OR 'survey' OR 'surveillance'  
(2) 'stroke' OR 'ischaemic stroke' OR 'ischemic stroke' OR 'intracerebral' OR 'intraparenchymal' OR 
'subarachnoid' OR 'haemorrhage' OR 'hemorrhage' OR 'ischemic stroke' AND .tw  
(3) #1 AND #2 AND (2008:py OR 2009:py OR 2010:py OR 2011:py OR 2012:py OR 2013:py OR 
2014:py OR 2015:py), human, English  
Scopus (n=1966) 
Search (TITLE ( "population-based"  OR  "community-based"  OR  "community"  OR  "epidemiology"  OR  
"epidemiological"  OR  "incidence"  OR  "attack rates"  OR  "survey"  OR  "surveillance"  OR  "mortality"  OR  
"morbidity"  OR  "fatality"  OR  "case fatality"  OR  "trends" ) )  AND  ( TITLE ( "stroke"  OR  "ischaemic 
stroke"  OR  "ischemic stroke"  OR  "intracerebral"  OR  "intraparenchymal"  OR  "subarachnoid"  OR  
"haemorrhage"  OR  hemorrhage ) )  AND  ( LIMIT-TO ( PUBYEAR ,  2014 )  OR  LIMIT-TO ( PUBYEAR ,  
2013 )  OR  LIMIT-TO ( PUBYEAR ,  2012 )  OR  LIMIT-TO ( PUBYEAR ,  2011 )  OR  LIMIT-TO ( 
PUBYEAR ,  2010 )  OR  LIMIT-TO ( PUBYEAR ,  2009 )  OR  LIMIT-TO ( PUBYEAR ,  2008 ) )  AND  ( 
LIMIT-TO ( DOCTYPE ,  "ar" )  OR  LIMIT-TO ( DOCTYPE ,  "ip" ) )  AND  ( LIMIT-TO ( LANGUAGE ,  
"English" ) ) 
ScienceDirect (n=811) 
Limitation: pub-date > 2007 and pub-date < 2015 and TITLE ( "stroke" OR "ischaemic stroke" OR "ischemic 
stroke" OR "intracerebral" OR "intraparenchymal" OR "subarachnoid" OR "haemorrhage" OR hemorrhage OR 
"ischemic stroke" ) AND TITLE ( "mortality" OR "morbidity" OR "fatality" OR "case fatality" OR "trends" OR 
"population-based" OR "community-based" OR "community" OR "epidemiology" OR "epidemiological" OR 
"incidence" OR "attack rates" OR "survey" OR "surveillance") 
Data collection 
Authors of each eligible study were contacted with a request for de-identified individual participant data (IPD) 
on stroke outcomes up to 5 years after stroke. Outcomes included mortality (date, time of stroke, date of death), 
functional outcomes and health-related quality of life. Data on participant characteristics were requested if 
available including socio-demographics (age, sex, marital status, education, occupation, socioeconomic 
position), pre-stroke health including body mass index, health behaviors (smoking, alcohol use), pre-stroke 
function (dependency, institutional residence), pre-stroke medication, history of comorbidities (atrial fibrillation, 
hypertension, ischemic heart disease, peripheral vascular disease, transient ischemic attack, diabetes, dementia), 
stroke-related factors (stroke severity, stroke type, the year of stroke occurrence), treatment and management 
(hospital admission, time to hospital, admission and discharge medication, neuroimaging, carotid investigation, 
echocardiography and surgical intervention) and post-stroke factors (depression and recurrence). Data provided 
were checked again with published data, where possible, and if discrepancies were identified, clarification was 
sought from authors. When no response was provided to data requests or no response from authors, we checked 
whether results of sex differences were reported in published papers.  
Data management 
Study-specific outcomes and variable definitions (i.e. covariates) were recorded and, where necessary, recoded 
to create common variables with consistent definitions (e.g. stroke severity). Following recoding, 13 datasets 
were then merged into one common database using study identification numbers.   
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Data S2. 
 
Measurement of potential confounding factors of sex difference in NIHSS of stroke at 
acute stroke 
 
Socio-demographics 
Data on age at the index stroke were available in all studies without age restriction. Race data from studies in 
Melbourne and Matão were categorised as Caucasian/Non-Caucasian. Educational level (studies conducted in 
Oxford, Joinville, Melbourne and Matão) was divided into two groups with the cut-off point of completing 
secondary education (grade 12). Classification of socioeconomic position (SEP) includes three groups: 
professional / non-manual (skilled + unskilled) / manual (skilled + unskilled) in 4 studies (Oxford, Melbourne, 
and Perth). Data on marital status (Oxford, Perth, Orebro and Matão) were categorized into 2 group: married / 
unmarried (including single, divorced, and widowed). 
Pre-stroke health  
Co-morbidities 
Analysis of binary data of self-reported history of diabetes (4 studies: Oxford, Melbourne, Perth and Orebro), 
dementia (3 studies Melbourne, Orebro and Matão), and cardiovascular diseases including ischaemic heart 
disease (all studies), atrial fibrillation (all studies), hypertension (all studies), transient ischaemic attack (all 
studies), and peripheral vascular disease (5 studies: Oxford, Melbourne, Orebro, Dijon and Matão) were 
performed.  
Body mass index (BMI) was recorded in 5 studies including Oxford, Joinville, Perth, Martinique and Porto. 
Pre-stroke medication 
Data on pre-stroke use of antihypertensive and antiplatelet agents were available in 5 studies (Joinville, 
Melbourne, Perth, Auckland and Tartu) and information on use of anticoagulants before stroke was only 
available in 2 studies (Melbourne and Auckland). 
Smoking and alcohol use 
Smoking status, which was recorded in 7 studies (not including Tartu), was categorized into 3 levels: never / 
former / current. Data on alcohol consumption were available in 6 studies. Alcohol use was analysed as 3 groups 
– no / current drinkers / ex-drinkers in 3 studies (Perth, Dijon, Matão) or 4 groups – no / not heavy drinkers / 
heavy drinkers / ex-drinkers in 3 studies (Oxford, Melbourne and Auckland) which depend on available data 
within different studies.  
Pre-stroke dependency 
Pre-stroke functional status was assessed according to residing in an institution before stroke in 4 studies 
(Melbourne, Perth, Orebro and Dijon), the pre-stroke Barthel Index in 3 studies (Melbourne, Perth and Orebro) 
or pre-stroke modified Rankin Score (mRS) in 4 studies (Oxford, Perth and Tartu). Pre-stroke dependency was 
defined as pre-stroke Barthel <20 or pre-stroke mRS>2. 
Management at acute stroke 
Hospital admission  
Data on whether the patient was admitted to hospital were available in all studies. 
Delay to hospital 
Analyses of these data were based on the time from stroke onset to admission time. Among 3 studies with these 
data (Oxford, Perth and Tartu), we calculated the time to hospital from time of stroke onset to time of admission 
and then categorized into them three groups (≤4.5 hours / 4.5 hours-24 hours / >24 hours). Delay to hospital was 
defined as a longer time for admission to hospital (i.e. > 24 hours). 
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Table S1. Eligible ‘ideal’ population-based studies of stroke with long-term outcome data available 
through systematic search. 
Study Year Baseline (N) Data on NIHSS   Notes 
13 studies for which long-term IPD 
were provided (n=18,342) 
    
Oxford, UK4 ’02-‘13 1374 ✓  
Joinville, Brazil5  ’09-‘14 2357 ✓  
Melbourne, Australia6 ’96-‘99 1316 ✓  
Arcadia, Greece7  ’93-‘95 555   
Perth, Australia8 ’00-‘01 183 ✓  
Orebro, Sweden9  ’99-‘00 377 ✓  
Dijon, France10  ’87-‘12 4621 ✓ (only available during 
the year ’06-’12; n=1505) 
 
Martinique, French West Indies11 ’98-‘99 580  Other severity instrument (Barthel Index) 
Porto, Portugal12 ’98-‘00 688  Other severity instrument (Unified 
Neurological Stroke Scale) 
Auckland, NZ13 ’02-‘03 1423  Other severity instrument (Glasgow Coma 
Scale) 
L’Aquila, Italia14 ’94-‘98 4353  Other severity instrument (loss of 
consciousness) 
Matão, Brazil15 ’03-‘04 81 ✓  
Tartu, Estonia16  ’02-‘03 433 ✓ (mapped from 
Scandinavian Stroke 
Scale) 
 
9 studies for which long-term IPD 
were not provided (n=9,985) 
    
Ludwigshafen, Germany 17 ‘06-‘07 725  No information of severity measurement 
Warsaw, Poland 18,19 ‘05 127 ✓ No sex-specific findings in sex difference in NIHSS 
South London, UK 20 ‘95-‘06 3373 ✓  
Erlangen, Germany 21 ‘98-‘06 1631  Other severity instrument (Barthel Index) 
Malmo, Sweden 22 ‘89-‘92 2290  Other severity instrument (Katx Index) 
Aeolian Islands, Italia 23 ’99-‘00 62  No information of severity measurement 
Vibo Valentia, Italia 24 ‘96 321  No information of severity measurement 
Rural Tanzania, Africa25 ‘03-‘06 130  Other severity instrument (Barthel index) 
Valley of Aosta, Italy 26 ‘04-‘08 1326  No information of severity measurement 
National Institute Health Stroke Scale=NIHSS 
✓ denotes study with data 
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Table S2. Data collection methods of study factors across eight studies. 
Study Source of data 
Oxford4 Pre-morbid medication and vascular risk factors were obtained from the patients or relative, hospital records, and general 
practice records.  
Atrial fibrillation (AF) was defined as either a known history with a confirmation from primary care or hospital records. 
Blood pressure (BP) was recorded from the general practice records.  
Premorbid modified Rankin score (mRS) was recorded from self-report questionnaire. 
Joinville5 A self-reported history or current treatment for cardiovascular diseases and risk factors, smoking and alcohol was obtained 
from patients or their relatives by research nurses. 
Melbourne6 Risk factors and management of risk factors were recorded by trained data collectors using a standardised questionnaire. 
Supporting data were collected from patients, relatives, medical records and treating doctor.  
Dementia, hypertension, peripheral vascular disease (PVD), prior transient ischemic attack (TIA), and prior myocardial 
infarction were defined as a known history.  
Diabetes was defined as either a known history or current presentation with fasting blood glucose ≥7.0 mmol/L.  
AF was defined as either a known history or current presentation confirmed on ECG.  
Smoking status was classified from self-report as current smoker, ex-smoker, or never smoked. 
Prestroke disability was recorded from self-report questionnaire using the Barthel Index.  
Perth8 The presence of heart failure was based on clinical criteria that included 1 of the following: raised venous pressure, gallop 
cardiac rhythm, and crepitations at the lung bases.  
The presence of AF required confirmation by an ECG within 1 month of the onset of stroke.  
Premorbid levels of physical disability were based on self-report or proxy sources (caregivers or medical records for those 
patients who were deceased or disabled) with the modified Barthel Index and mRS. 
Orebro9 A record of medical history was taken and logistic data regarding hospital treatment period and investigations were noted.  
Premorbid mRS was recorded from self-report questionnaire. 
Dijon10 History of hypertension was defined as known hypertension in a patient’s medical history (either self-reported or from medical 
notes) or when a patient was treated with anti-hypertensive agents.  
A history of AF, previous myocardial infarction, a history of TIA were recoded.  
Pre-stroke treatments by anticoagulants, antiplatelet agents and antihypertensive treatments were noted. 
Matão15 Risk factors and management of risk factors were recorded by trained data collectors using a standardised questionnaire. 
Tartu16 Stroke risk factors were recorded based on case history and clinical evaluations. History of disease was obtained from 
outpatients and hospital records, family and patients.  
BP was measured at admission. 
AF was confirmed by ECG. 
Myocardial infarction was confirmed by ECG or autopsy.  
Premorbid mRS was recorded from self-report questionnaire. 
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Table S3. Characteristics of included cohort studies by sex among patients with NIHSS data, for studies conducted in Oxford, Joinville, Melbourne and Perth. 
Characteristic Oxford4 Joinville5 Melbourne6 Perth8 
 IS ICH IS ICH IS ICH IS ICH 
 Men Women Men Women Men Women Men Women Men Women Men Women Men Women Men Women 
Number of cases 550 537 48 46 780 714 129 94 357 387 73 71 61 62 8 7 
SOCIODEMOGRAPHIC                 
Mean (SD) Age 72.4 
(12.0) 
77.7 
(12.1) 
69.5 
(14.3) 
73.5 
(16.2) 
63.5 
(12.5) 
66.8 
(15.7) 
58.2 
(15.4) 
62.5 
(15.5) 
72.4 
(12.7) 
76.3 
(14.3) 
70.3 
(13.5) 
75.2 
(15.2) 
74.0 
(12.5) 
78.0 
(10.1) 
68.0 
(18.5) 
73.5 
(12.3) 
Race (%)                 
Caucasian - - - - - - - - 93.0 94.6 91.8 93.0 - - - - 
Non-Caucasian         3.4 2.8 4.1 5.6     
Unknown         3.6 2.6 4.1 1.4     
Marital status (%)                 
Single/widowed 23.6 54.0 12.5 39.1 - - - - - - - - 64.0 37.1 87.5 57.1 
Married 65.3 34.6 62.5 54.4         32.8 58.1 12.5 42.9 
Unknown 11.1 11.4 25.0 6.5         3.3 4.8 0.0 0.0 
Education level (%)                 
≤ Grade 12 65.1 66.5 47.9 60.9 93.9 93.7 93.8 95.7 51.3 56.1 39.7 47.9 - - - - 
> Grade 12 15.6 9.1 8.3 6.5 5.8 5.6 6.2 3.2 43.4 42.4 53.4 52.1     
Unknown 19.3 24.4 43.8 32.6 0.4 0.7 0.0 1.1 5.3 1.6 6.9 0.0     
Social class (%)                 
Professional 17.1 6.5 6.3 4.4 - - - - 38.7 32.8 38.4 42.3 21.3 3.2 12.5 0.0 
Non-manual 21.8 27.9 20.8 47.8     10.4 14.2 16.4 9.9 6.6 12.9 0.0 0.0 
Manual 41.1 35.9 35.4 19.6     43.7 35.9 38.4 25.4 21.3 15.8 50.0 14.3 
Unknown 20.0 29.6 37.5 28.3     7.3 17.1 6.9 22.5 50.8 58.1 37.5 85.7 
PRE-STROKE HEALTH                 
Modified Rankin Score (%)                 
0-2 85.8 73.6 79.2 69.6 - - - - - - - - 82.0 67.7 12.5 14.3 
3-5 13.6 25.1 10.4 26.1         16.4 24.2 75.0 71.4 
Unknown 0.6 1.3 10.4 4.4         1.6 8.1 12.5 14.3 
Institutional residence (%)                 
Yes - - - - - - - - 6.4 13.2 6.9 15.5 4.9 9.7 62.5 14.3 
No         93.3 86.3 91.8 84.5 95.1 90.3 12.5 42.9 
Unknown         0.3 0.5 1.4 0.0 0.0 0.0 25.0 42.9 
Barthel Index (%)                 
20 - - - - - - - - 60.2 49.6 54.8 36.6 - - - - 
<20         13.5 19.6 6.9 14.1     
Unknown         26.3 30.8 38.4 49.3     
MEDICAL HISTORY                 
Atrial fibrillation (%)                 
Yes 21.1 25.5 16.7 10.9 4.6 6.0 0.0 1.1 22.4 26.6 12.3 11.3 19.7 24.2 0.0 28.6 
No 78.9 74.3 83.3 89.1 95.4 94.0 100.0 98.9 77.0 73.1 84.9 88.7 75.4 74.2 75.0 71.4 
Unknown 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 1.6 0.0 0.0 
Hypertension (%)                 
Yes 61.3 66.7 54.2 47.8 65.8 72.6 69.0 77.7 53.2 58.9 53.4 64.8 54.1 61.3 37.5 42.9 
No 38.7 33.3 41.7 52.2 34.2 27.5 31.0 22.3 45.9 40.6 45.2 35.2 41.0 38.7 37.5 57.1 
Unknown 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.8 0.5 1.4 0.0 4.9 0.0 25.0 0.0 
Ischemic heart disease (%)                 
Yes 16.2 9.3 8.3 0.0 7.6 3.5 3.1 1.1 16.8 14.0 15.8 2.8 18.0 8.1 12.5 0.0 
No 83.5 90.7 83.3 97.8 92.4 96.5 96.9 98.9 82.6 85.8 83.6 97.2 78.7 88.7 62.5 100.0 
Unknown 0.4 0.0 8.3 2.2 0.0 0.0 0.0 0.0 0.6 0.3 1.4 0.0 3.3 3.2 25.0 0.0 
Peripheral vascular disease (%)                 
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Table S3. Characteristics of included cohort studies by sex among patients with NIHSS data, for studies conducted in Oxford, Joinville, Melbourne and Perth. 
Characteristic Oxford4 Joinville5 Melbourne6 Perth8 
 IS ICH IS ICH IS ICH IS ICH 
 Men Women Men Women Men Women Men Women Men Women Men Women Men Women Men Women 
Yes 9.1 5.6 2.1 0.0 - - - - 12.6 5.7 6.9 2.8 - - - - 
No 90.7 94.2 97.9 100.0     86.8 94.1 91.8 95.8     
Unknown 0.2 0.2 0.0 0.0     0.6 0.3 1.4 1.4     
Transient ischemic attack (%)                 
Yes 14.4 11.9 10.4 10.9 2.6 2.4 3.9 0.0 9.8 9.8 8.2 5.6 21.3 11.3 12.5 14.3 
No 85.6 87.9 89.6 89.1 97.4 97.6 96.1 100.0 89.6 89.7 89.0 94.4 67.2 80.7 50.0 85.7 
Unknown 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 2.7 0.0 11.5 8.1 37.5 0.0 
Diabetes (%)                 
Yes 15.6 12.1 8.3 8.7 - - - - 19.9 18.4 9.6 4.2 24.6 21.0 0.0 14.3 
No 84.4 87.9 91.7 91.3     79.6 91.7 90.4 95.8 75.4 79.0 75.0 85.7 
Unknown 0.0 0.0 0.0 0.0     0.6 0.0 0.0 0.0 0.0 0.0 25.0 0.0 
Dementia (%)                 
Yes - - - - - - - - 4.5 9.3 4.1 15.5 - - - - 
No         81.8 78.3 84.9 81.7     
Unknown         13.7 124 11.0 2.8     
Smoking (%)                 
Current 17.5 13.8 20.8 4.4 29.6 13.2 34.9 59.6 20.2 13.7 16.4 9.9 11.5 4.8 25.0 0.0 
Former 53.5 28.3 39.6 28.3 41.3 18.6 34.1 25.5 46.2 22.5 53.4 19.7 52.5 14.5 25.0 14.3 
Never 28.4 56.4 27.1 56.5 29.1 68.2 31.0 14.9 29.4 55.0 23.3 52.1 18.0 53.2 25.0 42.9 
Unknown 0.7 1.5 12.5 10.9 0.0 0.0 0.0 0.0 4.2 8.8 6.9 18.3 18.0 27.4 25.0 42.9 
Alcohol use (%)                 
Non-drinkers 28.6 57.0 16.7 41.3 49.0 83.1 19.4 2.1 20.2 46.0 15.1 35.2 27.9 30.7 25.0 28.6 
Not heavy drinkers 63.8 34.6 45.8 32.6 38.7 15.8 34.9 18.1 56.3 41.3 53.4 38.0 9.8 14.5 0.0 0.0 
Heavy drinkers 3.3 1.7 8.3 2.2 13.3 1.1 45.7 79.8 8.2 1.3 12.3 1.4 29.5 17.7 37.5 0.0 
Ex-drinkers - - - - - - - - 8.7 1.3 11.0 2.8 6.6 1.6 0.0 0.0 
Unknown 4.4 6.7 29.2 23.9 0.0 0.0 0.0 0.0 6.7 10.1 8.2 22.5 26.2 35.5 37.5 0.0 
Mean (SD) Body mass index  26.4 (4.6) 26.2 (5.8) 25.3 (3.4) 23.2 (7.5) 26.7 (4.2) 26.9 (5.5) 27.0 (4.8) 25.8 (5.0) - - - - 25.9 (4.0) 25.0 (4.0) - - 
Medication                 
Antihypertensives (%)                 
Yes - - - - 61.2 69.5 55.0 69.2 53.3 61.8 41.1 49.3 45.9 56.5 37.5 42.9 
No     38.9 30.5 45.0 30.9 46.2 38.0 57.5 50.7 47.5 40.3 37.5 57.1 
Unknown     0.0 0.0 0.0 0.0 0.3 0.3 1.4 0.0 6.6 3.2 25.0 0.0 
Antiplatelet (%)                 
Yes - - - - 30.1 33.6 20.9 24.5 30.5 30.5 20.6 28.2 29.5 43.6 25.0 42.9 
No     69.9 66.4 79.1 75.5 69.2 69.5 78.1 71.9 70.5 51.6 62.5 57.1 
Unknown     0.0 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 4.8 12.5 0.0 
STROKE-RELATED 
FACTORS 
                
Hospital admission (%) 82.7 83.1 100.0 97.8 100.0 100.0 100.0 100.0 98.0 99.0 100.0 98.6 77.1 83.9 100.0 57.1 
Ischemic stroke subtype                 
Atherothrombotic - - - - 27.9 26.0 - - 23.8 18.1 - - - - - - 
Cardioembolic     27.4 28.4   26.3 25.3       
Lacunar     22.4 18.3   19.1 13.2       
Other Causes     22.2 27.3   1.1 1.6       
Undetermined     0.0 0.0   29.7 41.9       
Time to hospital† (%)                 
≤ 4.5 hours - - - - 41.4 45.1 57.4 64.9 - - - - 14.9 19.2 25.0 0.0 
> 4.5 – 24 hours     27.7 24.7 24.8 20.2     8.5 13.5 12.5 0.0 
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Table S3. Characteristics of included cohort studies by sex among patients with NIHSS data, for studies conducted in Oxford, Joinville, Melbourne and Perth. 
Characteristic Oxford4 Joinville5 Melbourne6 Perth8 
IS ICH IS ICH IS ICH IS ICH 
Men Women Men Women Men Women Men Women Men Women Men Women Men Women Men Women 
> 24 hours 28.6 26.9 14.7 11.7 10.6 19.2 0.0 25.0 
Unknown 2.3 3.4 3.1 3.2 66.0 18.1 62.5 75.0 
Bold denotes statistically significant differences between men and women; IS, Ischemic stroke; ICH, intracerebral hemorrhage; † among hospitalized patients 
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Table S4. Characteristics of included cohort studies by sex among patients with NIHSS data, for studies conducted in Orebro, Dijon, Mãtao and Tartu. 
Characteristic Orebro9 Dijon10 Mãtao15 Tartu16 
IS ICH IS ICH IS ICH IS ICH 
Men Women Men Women Men Women Men Women Men Women Men Women Men Women Men Women 
Number of cases 125 149 25 19 568 670 92 105 41 26 8 3 121 178 27 28 
SOCIODEMOGRAPHIC 
Mean (SD) Age 73.1 
(10.5) 
77.1 
(10.7) 
71.9 
(11.5) 
75.6 (9.9) 71.7 
(15.3) 
77.2 
(15.8) 
71.0 
(15.8) 
76.6 (18.3) 65.1 
(12.3) 
64.5 
(12.6) 
62.9 (7.0) 68.7 (7.5) 68.1 
(10.9) 
75.6 
(10.9) 
63.6 (15.9) 68.1 (12.6) 
Marital status (%) 
Single/widowed 32.8 36.9 32.0 63.2 - - - - 26.8 38.5 25.0 66.7 - - - - 
Married 67.2 61.7 68.0 36.8 68.3 61.5 75.0 0.0 
Unknown 0.0 0.0 0.0 0.0 4.8 0.0 0.0 33.3 
Education level (%) 
≤ Grade 12 - - - - - - - - 80.5 96.2 75.0 33.3 - - - - 
> Grade 12 7.3 3.9 25.0 0.0 
Unknown 12.2 0.0 0.0 66.7 
PRE-STROKE HEALTH 
Modified Rankin Score (%) 
0-2 - - - - - - - - - - - - 87.6 87.1 85.2 82.1 
3-5 4.1 7.9 3.7 3.6 
Unknown 8.3 5.1 11.1 14.3 
Institutional residence (%) 
Yes 2.4 9.4 4.0 21.1 3.5 10.8 4.4 6.7 - - - - - - - - 
No 97.6 90.6 96.0 79.0 96.5 89.3 95.7 93.3 
Unknown 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Barthel Index (%) 
20 76.0 65.1 4.0 47.4 - - - - - - - - - - - - 
<20 6.4 7.4 68.0 5.3 
Unknown 17.6 27.5 28.0 47.4 
MEDICAL HISTORY 
Atrial fibrillation (%) 
Yes 20.8 26.2 24.0 5.3 14.6 19.0 11.9 20.2 2.4 0.0 0.0 0.0 30.6 41.6 7.4 7.1 
No 79.2 73.8 76.0 94.7 85.3 80.4 88.1 79.8 90.2 100 100 66.7 69.4 58.4 92.6 92.9 
Unknown 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 7.3 0.0 0.0 33.3 0.0 0.0 0.0 0.0 
Hypertension (%) 
Yes 31.2 42.3 32.0 31.6 66.2 70.6 68.3 64.9 63.4 69.2 87.5 66.7 55.4 71.4 63.0 71.4 
No 67.2 55.7 68.0 68.4 33.6 28.8 31.7 35.1 31.7 30.8 12.5 0.0 44.6 28.7 37.0 28.6 
Unknown 1.6 2.0 0.0 0.0 0.2 0.6 0.0 0.0 4.9 0.0 0.0 33.3 0.0 0.0 0.0 0.0 
Ischemic heart disease (%) 
Yes 19.2 14.8 8.0 0.0 16.3 12.7 8.9 7.0 2.4 11.5 12.5 0.0 38.0 43.8 22.2 32.1 
No 80.8 85.2 92.0 100.0 93.5 86.7 91.1 93.0 90.2 88.5 87.5 66.7 62.0 56.2 77.8 67.9 
Unknown 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 7.3 0.0 0.0 33.3 0.0 0.0 0.0 0.0 
Peripheral vascular disease (%) 
Yes 37.6 26.9 28.0 21.1 7.7 4.5 5.9 5.3 - - - - - - - - 
No 62.4 72.5 78.0 79.0 92.1 94.9 94.1 94.7 
Unknown 0.0 0.7 0.0 0.0 0.2 0.6 0.0 0.0 
Transient ischemic attack (%) 
Yes 20.0 13.4 4.0 10.5 6.6 8.8 5.9 3.5 9.8 3.9 0.0 0.0 7.4 8.4 0.0 0.0 
No 80.0 86.6 96.0 89.5 93.3 91.2 94.1 96.5 82.9 93.2 100.0 33.3 92.6 91.6 100.0 100.0 
Unknown 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 33.3 0.0 0.0 0.0 0.0 
Diabetes (%) 
Yes 20.8 16.1 8.0 10.5 - - - - - - - - - - - - 
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Table S4. Characteristics of included cohort studies by sex among patients with NIHSS data, for studies conducted in Orebro, Dijon, Mãtao and Tartu. 
Characteristic Orebro9 Dijon10 Mãtao15 Tartu16 
 IS ICH IS ICH IS ICH IS ICH 
No 78.4 81.9 92.0 89.5             
Unknown 0.8 2.0 0.0 0.0             
Dementia (%)                 
Yes 4.8 10.1 8.0 10.5 - - - - - - - - - - - - 
No 85.2 89.9 92.0 89.5             
Unknown 0.0 0.0 0.0 0.0             
Smoking (%)                 
Current 29.6 18.1 24.0 10.5 47.0 81.7 59.4 82.5 43.9 19.2 50.0 33.3 - - - - 
Former - - - - 23.2 2.5 15.8 2.6 - - - -     
Never 63.2 79.2 64.0 79.0 27.3 12.3 21.8 9.7 51.2 80.8 50.0 33.3     
Unknown 7.2 2.7 12.0 10.5 2.6 3.5 3.0 2.3 4.9 0.0 0.0 33.3     
Alcohol use (%)                 
Non-drinkers - - - - 86.6 95.6 77.1 95.6 70.7 100.0 75.0 33.3 - - - - 
Current drinkers*     11.5 2.3 20.8 3.5 22.0 0.0 25.0 33.3     
Ex-drinkers     - - - - - - - -     
Unknown     1.9 2.1 2.0 0.9 7.3 0.0 0.0 33.3     
STROKE-RELATED FACTORS                 
Hospital admission (%) 95.2 96.0 92.0 94.7 99.7 100.0 100.0 99.1 100.0 100.0 100.0 100.0 98.4 99.4 100.0 100.0 
Ischemic stroke subtype                 
Atherothrombotic 54.4 55.7 - - - - - - - - - - 28.9 25.8 - - 
Cardioembolic 12.8 14.1           28.1 39.3   
Lacunar 30.4 26.9           30.6 23.0   
Other Causes 1.6 1.3           12.4 10.7   
Undetermined 0.8 2.0           0.0 1.1   
Time to arrive hospital† (%)                 
≤ 4.5 hours - - - - - - - - - - - - 30.3 32.2 59.3 57.1 
> 4.5 – 24 hours             6.7 5.1 3.7 0.0 
> 24 hours             2.5 2.8 0.0 0.0 
Unknown             60.5 59.9 37.0 42.8 
Bold denotes statistically significant differences between men and women; IS, Ischemic stroke; ICH, intracerebral hemorrhage; † among hospitalized patients 
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Table S5. Severity of ischemic stroke by subtype among women and men. 
Study Number of cases (%) NIHSS, mean (IQR) NIHSS>7, n (%) More severe stroke 
Men Women Men Women Men Women RR (95% CI) 
Large-artery 
atherosclerosis 
Joinville5 247 (56.0%) 194 (44.0%) 4.0 (2.0-9.0) 5.0 (2.0-12.0) 74/247 (30.0%) 73/194 (37.6%) 1.26 (0.97-1.63) 
Melbourne6 85 (23.8%) 70 (45.2%) 4.0 (1.0-8.0) 4.0 (2.0-14.0) 22/85 (25.9%) 29/70 (41.4%) 1.60 (1.01-2.53) 
Orebro9 68 (45.0%) 83 (55.0%) 3.0 (2.0-10.5) 6.0 (3.0-10.0) 20/68 (29.4%) 34/83 (41.0%) 1.39 (0.89-2.19) 
Tartu16 35 (43.2%) 46 (56.8%) 12.0 (6.0-20.0) 13.0 (7.0-19.0) 22/35 (62.9%) 33/46 (71.7%) 1.14 (0.93-1.56) 
Pooled 435 (52.5%) 393 (47.5%) 4.0 (2.0-10.0) 6.0 (3.0-13.0) 138/435 (31.7%) 169/393 (43.0%) 1.32 (1.05-1.66)* 
Cardioembolism  
Joinville5 259 (47.3%) 289 (52.7%) 5.0 (2.0-12.0) 8.0 (3.0-16.0) 100/259 (38.6%) 150/289 (51.9%) 1.34 (1.11-1.63) 
Melbourne6 94 (49.0%) 98 (51.0%) 7.5 (4.0-14.0) 9.5 (5.0-17.0) 47/94 (50%) 58/98 (59.2%) 1.18 (0.91-1.54) 
Orebro9 16 (43.2%) 21 (56.8%) 4.0 (2.0-7.0) 12.0 (4.0-20.0) 4/16 (25.0%) 13/21 (61.9%) 2.48 (0.98-6.25) 
Tartu16 34 (32.7%) 70 (67.3%) 8.5 (4.0-20.0) 12.5 (4.0-20.0) 18/34 (52.9%) 43/70 (61.4%) 1.16 (0.80-1.68) 
Pooled 403 (45.7%) 478 (54.3%) 6.0 (3.0-13.0) 9.0 (3.0-17.0) 169/403 (41.9%) 264/478 (55.2%) 1.32 (1.08-1.60)* 
Small-vessel 
occlusion 
Joinville5 247 (56.5%) 190 (43.5%) 3.0 (2.0-4.0) 2.0 (1.0-5.0) 17/247 (6.9%) 20/190 (10.5%) 1.53 (0.82-2.84) 
Melbourne6 68 (57.1%) 51 (42.9%) 3.0 (2.0-4.0) 2.0 (1.0-5.0) 3/68 (4.4%) 6/51 (11.8%) 2.67 (0.70-10.2) 
Orebro9 38 (48.7%) 40 (51.3%) 4.0 (3.0-5.0) 3.0 (2.0-4.0) 2/38 (5.3%) 2/40 (5.0%) 0.95 (0.14-6.49) 
Tartu16 37 (47.4%) 41 (52.6%) 0.0 (0.0-3.0) 2.0 (0.0-8.0) 1/37 (2.7%) 11/41 (26.8%) 9.93 (1.33-74.2) 
Pooled 390 (54.8%) 322 (45.2%) 3.0 (2.0-4.0) 3.0 (1.0-5.0) 23 (5.9%) 39 (12.1%) 2.05 (1.23, 3.44)* 
Other etiology 
Joinville5 27 (39.7%) 41 (60.3%) 2.0 (1.0-8.0) 2.0 (1.0-6.0) 7/27 (25.9%) 10/41 (24.4%) 0.94 (0.41-2.18) 
Melbourne6 4 (40.0%) 6 (60.0%) 4.0 (1.5-8.5) 5.0 (1.0-10.0) 1/4 (25%) 2/6 (33.3%) 1.33 (0.16-11.5) 
Orebro9 2 (50.0%) 2 (50.0%) 7.5 (6.0-9.0) 14.5 (5.0-24.0) 1/2 (50.0%) 1/2 (50.0%) 1.00 (0.10-9.61) 
Tartu16 15 (44.1%) 19 (55.9%) 5.0 (0.0-7.0) 5.0 (1.0-15.0) 3/15 (20.0%)  9/19 (47.4%)  2.37 (0.76-7.36) 
Pooled 48 (41.4%) 68 (58.6%) 3.0 (1.0-7.5) 3.0 (1.0-10.0) 12/48 (25.0%) 22/68 (32.4%) 1.29 (0.64-2.61)* 
Undetermined 
Joinville5 - - - - - - - 
Melbourne6 106 (39.6%) 162 (60.5%) 5.0 (2.0-11.0) 4.0 (2.0-10.0) 39/106 (36.8%) 55/162 (34.0%) 0.92 (0.66-1.28) 
Orebro9 1 (25.0%) 3 (75.0%) 28.0 (NA) 3.0 (0.0-6.0) 1/1 (100%) 0/3 (0%) NA 
Tartu16 0 (0.0%) 1 (100%) - 7.5 (3.0-12.0) 0/0 (0%) 1/2 (50.0%) NA 
Pooled 107 (39.1%) 167 (61.0%) 5.0 (2.0-11.0) 4.0 (2.0-10.0) 40/107 (37.4%) 56 (33.5%) 0.90 (0.60-1.35)* 
National Institutes of Health Stroke Scale=NIHSS; Bold denotes statistically significant differences between 
men and women 
*RR was pooled using log-binominal regression with random-effects
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Table S6. List of covariates not meeting the criteria for confounding factors of sex difference in severity 
(NIHSS) of ischemic stroke. 
Study Covariates  
Oxford4 SEP, education, hypertension, AF, IHD, PVD, TIA, diabetes, BMI, smoking, marital status, alcohol, hospital admission, 
Joinville5 Stroke subtype, race, hypertension, AF, PVD, TIA, BMI, smoking, hospital admission (100%), pre-stroke medication 
(antihypertensives, antiplatelets, anticoagulants), delay to hospital, IHD, alcohol 
Melbourne6 Stroke subtype, race, SEP, education, hypertension, IHD, PVD, TIA, diabetes, smoking, alcohol, hospital admission, pre-
stroke medication (antiplatelets, anticoagulants, antihypertensives), institutional residence 
Perth8 SEP, hypertension, AF, IHD, TIA, diabetes, smoking, alcohol, delay to hospital, pre-stroke medication (antihypertensives, 
antiplatelets), institutional residence, pre-stroke Barthel, hospital admission 
Orebro9 Stroke subtype, age†, marital status, hypertension, AF, IHD, PVD, TIA, diabetes, dementia, pre-stroke Barthel, hospital 
admission, smoking 
Dijon10 Hypertension, IHD, PVD, TIA, alcohol, hospital admission, institutional residence 
Matão15 Race, marital status, education, age†, hypertension, AF, IHD, PVD, TIA, smoking, alcohol, hospital admission 
Tartu16 Stroke subtype, hypertension, AF, IHD, TIA, hospital admission, delay to hospital, pre-stroke medication (antihypertensives, 
antiplatelets) 
AF, Atrial fibrillation; BMI, body mass index; IHD, ischaemic heart disease; mRS, modified Rankin scale; 
NIHSS, National Institutes of Health Stroke Scale; PVD, peripheral vascular disease, TIA, transient ischemic 
attack; SEP, socioeconomic position. 
* Not meeting all 4 criteria (missing <20% of cases, associated with sex, associated with stroke severity, and
the inclusion of the covariate changed the magnitude of the sex coefficient by ≥10%) but to be included in the
final multivariable model
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Table S7. Analyses of heterogeneity in the sex differences in stroke severity (NIHSS>7) among eight 
population-based studies. 
No of studies Unadjusted Adjusted for covariates* 
I2 (%) PH RR (95% CI) Psub-group I2 (%) PH RR (95% CI) Psub-group 
Ischaemic stroke 
Geographic region 
Australasia 2 0.0 0.444 1.23 (1.02-1.48) 0.565 0.0 0.916 1.12 (0.93-1.35) 0.385 
Europe 4 0.0 0.533 1.36 (1.21-1.52) 0.0 0.680 1.16 (1.03-1.30) 
South America 2 0.0 0.925 1.41 (1.22-1.64) 0.0 0.413 1.32 (1.13-1.53) 
Pre-stroke function 
Unavailable 2 0.0 0.515 1.43 (1.24-1.64) 0.334 0.0 0.901 1.29 (1.12-1.49) 0.232 
Available 6 0.0 0.718 1.30 (1.18-1.44) 0.0 0.741 1.15 (1.04-1.27) 
Intracerebral hemorrhagic 
stroke 
Geographic region 
Australasia 2 0.0 0.958 1.26 (0.97-1.63) 0.515 0.0 0.948 1.21 (0.97-1.20) 0.503 
Europe 4 0.0 0.728 1.05 (0.89-1.24) 0.0 0.832 1.07 (0.91-1.26) 
South America 2 0.0 0.759 1.05 (0.88-1.25) 0.0 0.778 1.03 (0.87-1.24) 
Pre-stroke function 
Unavailable 2 0.0 0.665 1.12 (0.97-1.30) 0.483 0.0 0.779 1.12 (0.97-1.30) 0.549 
Available 6 0.0 0.935 1.04 (0.88-1.22) 0.0 0.983 1.03 (0.87-1.21) 
Bold denotes statistically significant differences between men and women; NIHSS, National Institutes of Health 
Stroke Scale; PH, P-value of heterogeneity; RR (95% CI), relative risk (95% confidence interval) of having more 
severe stroke (NIHSS>7) for women compared to men 
*List of covariates were demonstrated in main Table 2.
D
ow
nloaded from
 http://ahajournals.org by on December 28, 2018
Table S8. Testing the interactions between sex and two covariates: age and time period using a single 
pooled individual participant dataset in stroke severity. 
Unadjusted Adjusted for age 
Covariates RR* (95% CI) Pinteraction RR (95% CI) Pinteraction 
Ischaemic stroke 
Age (continuous) 1.35 (0.69-2.64) 0.793 
Age group 
≤65 years 1.19 (0.92-1.53) Ref - 
>65-75 years 1.23 (1.00-1.52) 0.855 - 
>75 years 1.25 (1.11-1.41) 0.705 - 
Year of stroke occurrence 
1996-2011 (continuous) 1.26 (1.15-1.41) 0.067 1.15 (1.03- 1.29) 0.128 
Intracerebral hemorrhagic stroke 
Age (continuous) 0.85 (0.52-1.39) 0.324 
Age group 
≤65 years 1.00 (0.86-1.16) Ref - 
>65-75 years 1.14 (0.97-1.33) 0.360 - 
>75 years 1.13 (1.03-1.24) 0.136 - 
Year of stroke occurrence 
1996-2011 (continuous) 1.16 (0.99, 1.36) 0.264 1.16 (1.09-1.22) 0.281 
Ref, Reference group 
* RR (95% CI), relative risk (95% confidence interval) of more severe stroke (NIHSS>7)
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Table S9. Sensitivity analyses of difference in National Institutes of Health Stroke Scale (NIHSS) 
continuous scores between women and men.  
Study N* Unadjusted Adjusted for 
Age Pre-stroke 
dependency 
All confounding 
factors 
MD (95% CI) MD (95% CI) MD (95% CI) MD (95% CI) 
Ischemic stroke 
Oxford4 1077 0.834 (0.265, 1.404) 0.391 (-0.177, 0.959) 0.478 (-0.089, 1.045) 0.247 (-0.228, 0.722) 
Joinville5 1494 0.856 (0.278, 1.434) 0.607 (0.038, 1.176) --- 0.607 (0.038, 1.176) 
Melbourne6 647 1.171 (0.190, 2.152) 0.697 (-0.260, 1.654) 1.141 (0.190, 2.091) 0.645 (-0.334, 1.625) 
Perth8 123 -0.466 (-2.893, 1.960) -1.162 (-3.596, 1.215) -0.681 (-3.240, 1.876) -1.162 (-3.596, 1.215) 
Orebro9 274 1.220 (-0.029, 2.469) 1.102 (-0.196, 2.373) 1.021 (-0.210, 2.252) 0.853 (-0.278, 1.984)
Dijon10 1238 1.130 (0.467, 1.794) 0.640 (-0.017, 1.297) 0.086 (0.213, 1.500) 0.018 (-0.703, 0.7381) 
Matão15 67 3.330 (0.095, 6.564) 3.337 (0.078, 6.595) --- 3.337 (0.078, 6.595) 
Tartu16 280 2.477 (0.742, 4.213) 1.182 (-0.619, 2.983) 1.729 (0.078, 3.380) 1.122 (-0.911, 2.900)
Pooled 5,200 1.011 (0.700, 1.323) 0.601 (0.296, 0.905) 0.802 (0.440, 1.164) 0.426 (0.095, 0.757) 
Intracerebral 
haemorrhage 
Oxford4 223 1.996 (-1.661, 5.654) 1.96 (-1.748, 5.671) --- --- 
Joinville5 94 0.207 (-2.380, 2.793) -0.118 (-2.718, 2.482) --- --- 
Melbourne6 114 4.139 (0.598, 7.680) 3.572 (0.014, 7.129) --- --- 
Perth8 15 1.932 (-10.391, 
14.257) 
1.081 (-11.677, 13.840) --- --- 
Orebro9 44 2.912 (-2.450, 8.276) 3.751 (-1.649, 9.150) --- --- 
Dijon10 197 0.914 (-1.579, 3.406) 0.460 (-2.044, 2.964) --- --- 
Matão15 11 6.046 (-9.800, 21.891) 0.627 (-10.243, 25.496) --- --- 
Tartu16 55 -0.828 (-5.104, 3.449) -0.706 (-5.074, 3.662) --- --- 
Pooled 753 1.654 (0.188, 3.120) 1.452 (-0.027, 2.931)
Bold denotes statistically significant results; MD=mean difference 
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Figure S1. Distribution of the National Institutes of Health Stroke Scale (NIHSS) scores by sex 
among those with stroke (both ischemic and intracerebral hemorrhagic stroke) in each study. 
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More severe stroke was defined as National Institutes of Health Stroke Scale >7. 
NOTE: Weights are from random effects analysis
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Figure S2. Difference in stroke severity between women and men with ischemic 
stroke: unadjusted (top) and adjusted (bottom) random-effects meta-analyses 
among 6 studies. 
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More severe stroke was defined as National Institutes of Health Stroke Scale >7. 
NOTE: Weights are from random effects analysis
Overall  (I-squared = 0.0%, p = 0.983)
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Figure S3. Difference in stroke severity between women and men with intracerebral 
haemorrhage (ICH): unadjusted (top) and adjusted (bottom) random-effects meta-
analyses among 6 studies. 
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